Remove 2005 Remove Cannabinoids Remove Clinical Trials
article thumbnail

Why we haven’t cured cancer

Otherside Farms

Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. Reduction of bone cancer pain by activation of spinal cannabinoid receptor 1 and its expression in the superficial dorsal horn of the spinal cord in a murine model of bone cancer pain.

article thumbnail

Best strains and terpenes for focus and flow state

The Cannigma

There is certainly some evidence that cannabis may be helpful with increasing focus, in the right dose with the right terpenes and cannabinoids. The short answer is maybe – it depends on several factors, including the cannabinoids and terpenes in your weed, as well as how much you consume. It starts with the right cannabinoids.

Terpenes 118
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

article thumbnail

New Study: Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013–2017 Traffic Safety Culture Index

Cannabis Law Report

Association of Recreational Cannabis Laws in Colorado and Washington State With Changes in Traffic Fatalities, 2005–2017. Cannabis Cannabinoid Res. 9-tetrahydrocannabinol on driving performance: a randomized clinical trial. Santaella-Tenorio J, Wheeler-Martin K, DiMaggio CJ, Castillo-Carniglia A, Keyes KM, Hasin D, et al.

Policy 45
article thumbnail

Marijuana-Based Parkinson’s Medication Moves Forward

CannaMD

In a 2005 paper , Dr. Bob Melamede noted that endocannabinoid dysregulation might be a causal factor in the disease’s development, detailing how the Parkinson’s disease-related glutamatergic problems of lab rodents could be “suppressed by exo- as well as endocannabinoids.” To learn more about GB Sciences, see: GBSciences.com.

article thumbnail

Marijuana and HIV: Much More Than Palliative Aid

Greencamp

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. But I haven’t seen any clinical trials looking at the direct effects of THC on the virus. What is HIV and how is it manifested?

Marijuana 110
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

The recreational use of cannabis is well known and attributed to its power as a psychotropic plant, specifically due to the cannabinoid tetrahydrocannabinol (THC). These were news stories focusing on the use of cannabinoids for chronic cancer pain or inhibiting tumour growth, and mental illness. 2016 ; Sznitman et al. Discussion.